Biotech Healthcare proudly introduced its newest advancement in intraocular lens technology — Optiflex XTENSE Comfort Plus, a Full Visual Range EDOF IOL, during the ESCRS 2025 meeting in Copenhagen. The product launch at Biotech’s booth drew widespread attention and appreciation from leading ophthalmic surgeons worldwide, many of whom shared promising early clinical experiences and positive outcomes with the lens.
Launch Highlights from ESCRS 2025:
At the Biotech booth, several distinguished surgeons presented their first-hand experiences with Optiflex XTENSE Comfort Plus:
- Dr. Altan Ozcan reported that this lens offers very good near distance and intermediate vision. He noted that his patients have not experienced discomfort related to glares, haloes or any vision disturbances. In his words, “Patients are enjoying sharp near and intermediate vision with Optiflex XTENSE Comfort Plus with none of the bothersome side effects like glare or halo
- Dr. Sri Ganesh (India), Dr. D. Ramamurthy (India), and Dr. Formanek (Austria) joined the celebrations and discussions. Dr. Sri Ganesh and Dr. D. Ramamurthy shared insights from their surgical outcomes and patient feedback using this new lens.
Their observations align closely with the product’s engineered strengths - a purely refractive optical profile that avoids diffractive rings, delivering high-definition vision across near, intermediate, and distance without compromise.
Impact and Implications:
The launch of Optiflex XTENSE Comfort Plus stands to mark a turning point in cataract and presbyopia correction:
- Enhanced Patient Satisfaction: By minimizing visual side effects and improving visual comfort, patient quality of life is expected to increase.
- Expanded Surgical Options: Surgeons now have access to an EDOF solution that combines wide-range vision performance with reduced optical disturbances.
- Global Adoption: With leading clinicians from India and Europe endorsing the lens, the global footprint of Optiflex XTENSE Comfort Plus is poised to grow.
On this occasion, a company representative stated “The enthusiastic response to Optiflex XTENSE Comfort Plus at ESCRS 2025 reaffirms our commitment to making Access to Innovation a reality for surgeons and patients worldwide. This launch reflects our dedication to creating technologies that empower doctors and provide patients with an uncompromised vision.”
FURTHER INFORMATION:
Visit: https://biotechhealthcare.com/products/optiflex-xtense-comfort-plus
